Titterton Lewis H jr 4

What Happened

• Lewis H. Titterton Jr, a director of Anixa Biosciences, reported a purchase of 12,000 common shares on 2026-07-20 at $3.47 per share, for a total outlay of $41,640. The transaction is coded "P" (purchase) and listed as an open-market or private purchase. Purchases are generally viewed as a more informative (bullish) signal than sales, though motivations are not disclosed.

Key Details

• Transaction date: 2026-07-20
• Price per share: $3.47; Shares purchased: 12,000; Total value: $41,640
• Transaction code: P = Purchase (open-market or private purchase)
• Shares owned after transaction: not specified in the provided filing
• Filing timeliness: Reported and filed on 2026-07-20 (same-day filing per the report); no late-filing indication
• No 10b5-1 plan, tax-withholding, or other footnotes were provided in the supplied transaction details

Context

• This is a straightforward insider buy of common shares. The dollar amount ($41.6K) is modest; investors should consider this alongside other insider activity, recent company news, and fundamentals. As always, insider purchases indicate an acquisition of stock but do not guarantee future performance.